Insider Trading & Ownership of Tactic Pharma LLC

Location
Lake Forest, IL
Summary
The estimated value of insider holdings of Tactic Pharma LLC is at least $17,303,519 dollars as of 26 Sep 2025. Tactic Pharma LLC is the 10%+ Owner of Monopar Therapeutics and owns shares of Monopar Therapeutics (MNPR) stock worth about $17.3M.
Signature
/s/ Chandler Robinson, Attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when Tactic Pharma LLC files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Tactic Pharma LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MNPR Monopar Therapeutics 10%+ Owner $17,303,519 -$36,166,647 -68% 24 Sep 2025

Insider Transactions Reported by Tactic Pharma LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.